Abstract:AIM: To investigate the change of regional cerebral metabolism rate of glucose (rCMRglc) with the treatment of hydro-fluoxetine (prozac) and relationship with the changes of neuropsychology in patients with first-episode depression in the hope of providing some biological evidences for clinical diagnosis of depression. METHODS: Fourteen patients with first-episode depression from Shanghai Municipal Mental Healthy Center between January and September 2003 were selected. Assessment on clinical symptom and cognitive function linical diagnoses of depression with examination of positronemission tomography were done before treatment. After 12-weeks treatment with fluoxertine hydrochloride (mean dosage was 20 mg per day), the above examination and assessment were conducted again in 8 patients (the reducing score rate > 50% of Hamilton depression rating scale). In the same period, 11 healthy persons from body health center of Huashan Hospital were only detected with positronemission tomography and Hamilton depression rating scale. ① Semi-quantitative index of rCMRglc of different region of brain was observed in depression group and healthy control group. Semi-quantitative index of rCMRglc of different region of brain before and after treatment was observed in the depression group. ② Pearson correlation analysis was done on the changes of rCMRglc and the changes of every factor of Wechsler Memory Scale (WMS) after the treatment of fluoxertine hydrochloride in the depression group. ③ The changes of 1→100, 100→1, accumulation, pictures and recognition of the WMS were considered as dependent variable, and the changes of rCMRglc at the corresponding region as independent variable, and then performing the stepwise multiple regression analysis. RESULTS: ① The rCMRglc in superior frontal gyrus and cingulated gyrus at the right side in the depression group was (1.11±0.05)MBq/cc,(1.21±0.07)MBq/cc, respectively, which was lower significantly than that in the healthy control group (P < 0.05). ② The rCMRglc in right superior frontal gyrus in the effective depression group (1.17±0.08)MBq/cc was higher obviously than that before treatment (1.14±0.08) MBq/cc(P < 0.05). ③ After treatment, the changes of 1→100 of WMS in depression patients had positive correlation with the change of rCMRglc in right hippocampus. The change of 100→1 and understanding was negative to the change of rCMRglc in left superior frontal gyrus. The change of accumulation was positive to the change of rCMRglc in left superior frontal gyrus. The change of pictures and tactile sensation was positive to the change of rCMRglc in left middle frontal gyrus. The change of recognition was negative to the change of rCMRglc in left inferior frontal gyrus and is negative to the change of rCMRglc in right inferior frontal gyrus and right cingulated gyrus. The change of association was positive to the change of rCMRglc in left cingulated gyrus. The change of recitation was positive to the change of rCMRglc in right occipital lobe (P < 0.05 or P < 0.01), and all was enrolled in regression equations, and the coefficient of product-moment ranged from 0.723-0.913. CONCLUSION: The fluoxertine hydrochloride can effectively enhance the rCMRglc in superior frontal gyrus of first-episode depression patients. The amelioration of memory ability is related to the alteration of the rCMRglc in depression patients.

Refractory Depression:Changes of Plasma Monoamine Neurotransmitter Metabolite Before and after Treatment

Proton magnetic resonance spectroscopy of the thalamus and hypothalamus in patients with depressive disorder before and after treatment

ComParison of different treatment regimens for refractory dePression efficacy

The Changes In, and Relationship Between, Plasma Nitric Oxide and Corticotropin‐releasing Hormone in Patients with Major Depressive Disorder

The Changes of Monamine Transmitter Content in Plasm of Post-Stroke Depression Patients and the Effect of Fluoxetine Hydrochloride to Post-Stroke Depression Treatment

A Proton Magnetic Resonance Spectroscopy Research on Hippocampus in Patients with Treatment-Resistant Depression

Abnormal Expression Profile of Plasma-Derived Exosomal Micrornas in Patients with Treatment-Resistant Depression

Serum Thyroid Hormone Levels Before and after Treatment in Patients with Treatment-Resistant Depression

The characteristics of sympathetic skin response in patients with depression

[Repetitive Transcranial Magnetic Stimulation Combined with Antidepressant Medication in Treatment of First-Episode Patients with Major Depression].

Fluoxetine Treatment for Major Depression Decreases the Plasma Levels of Cytokines

Characteristics of regional cerebral metabolic rate of glucose in association with the neuropsychological changes after the treatment of first-episode depression

The contribution of polyamine pathway to determinations of diagnosis for treatment-resistant depression: A metabolomic analysis

Hypothalamus-anchored Resting Brain Network Changes Before and after Sertraline Treatment in Major Depression.

High-frequency Rtms Treatment Increases Left Prefrontal Myo-Inositol in Young Patients with Treatment-Resistant Depression.

Repetitive transcranial magnetic stimulation in the treatment of resistant depression: changes of specific neurotransmitter precursor amino acids

Influence of mirtazapine on cognitive function in patients with depression:test of a Neuropsychological Training System and a MRI study

Resting-State fMRI in Predicting Response to Treatment With SSRIs in First-Episode, Drug-Naive Patients With Major Depressive Disorder

The Relevant Research of Thyroid Hormones and Clinical Features in Treatment-Resistant Depression

The potential predictors for treatment‐resistance depression after selective serotonin reuptake inhibitors therapy in Han Chinese: A resting‐state functional magnetic resonance imaging study

Altered Brain Function in Treatment-Resistant and Non-treatment-resistant Depression Patients: A Resting-State Functional Magnetic Resonance Imaging Study